High-Dose Idarubicin, Busulphan and Melphalan for Autologous Stem Cell Transplantation in Multiple Myeloma Responsive to DAV Chemotherapy: Comparison with a Historical Control

Publisher: Karger

E-ISSN: 1421-9662|115|1-2|9-14

ISSN: 0001-5792

Source: Acta Haematologica, Vol.115, Iss.1-2, 2006-01, pp. : 9-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract